Literature DB >> 10825065

Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium.

P Fernandez-Viladrich1, X Corbella, L Corral, F Tubau, A Mateu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10825065     DOI: 10.1086/517243

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  24 in total

1.  In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.

Authors:  Jimmy Yoon; Carl Urban; Christian Terzian; Noriel Mariano; James J Rahal
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

2.  Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii.

Authors:  L A Arroyo; A García-Curiel; M E Pachón-Ibañez; A C Llanos; M Ruiz; J Pachón; J Aznar
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

3.  Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin.

Authors:  Aspasia Katragkou; Emmanuel Roilides
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 4.  The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature.

Authors:  Matthew E Falagas; Sofia K Kasiakou; Sotirios Tsiodras; Argyris Michalopoulos
Journal:  Clin Med Res       Date:  2006-06

5.  Polymyxin B-Resistant Acinetobacter baumannii Clinical Isolate Susceptible to Recombinant BPI and Cecropin P1.

Authors:  C Urban; N Mariano; J J Rahal; E Tay; C Ponio; T Koprivnjak; J Weiss
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 6.  Polymyxins revisited.

Authors:  David Landman; Claudiu Georgescu; Don Antonio Martin; John Quale
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

7.  Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients.

Authors:  Stephanie J Wallace; Jian Li; Craig R Rayner; Kingsley Coulthard; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2008-07-07       Impact factor: 5.191

Review 8.  Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review.

Authors:  O Bargiacchi; A Rossati; P Car; D Brustia; R Brondolo; F Rosa; P L Garavelli; F G De Rosa
Journal:  Infection       Date:  2014-04-12       Impact factor: 3.553

Review 9.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

10.  Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia.

Authors:  G Christopher Wood; Scott D Hanes; Bradley A Boucher; Martin A Croce; Timothy C Fabian
Journal:  Intensive Care Med       Date:  2003-10-11       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.